Drug news
NICE recomends Xgeva (Amgen) for bone metastases
The latest draft guidance from NICE recommends Xgeva (denosumab)from Amgen:
�For adults with bone metastases from breast cancer
�For adults with bone metastases from solid tumours other than breast and prostate only if zoledronic acid or disodium pamidronate would otherwise be prescribed for these patients.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.